CLN - Industry Insights

Reliable QC, simplified: Swab-based controls for today’s diagnostic workflows

Streamlined quality assurance for clinical labs, without sacrificing accuracy or reliability.

ZeptoMetrix

As molecular diagnostics continue to advance, laboratories and assay developers face the challenge of maintaining accuracy, efficiency, and reproducibility in increasingly complex workflows. Quality control (QC) is essential to ensuring reliable results, yet traditional liquid controls can introduce additional handling steps and logistical constraints. ZeptoMetrix® NATtrol™ swab-based controls provide an innovative alternative, delivering the same trusted performance in a format that simplifies QC across testing platforms.

NATtrol swab controls are formulated with non-infectious, inactivated whole microorganisms to closely mimic a true clinical specimen and ensure confidence in your workflow. With the convenience of ambient shipping and storage (2-25 °C) and a shelf life of up to 24 months, these ready-to-use swabs minimize cold chain requirements while supporting consistent assay performance.

Key benefits include:

  • Versatile: Compatibility with a wide range of molecular assays and platforms
  • Convenient: Ready-to-use swabs that integrate seamlessly into routine workflows
  • Economic: Ambient shipping and storage eliminate costly cold chain expenses
  • Comprehensive: Full process controls monitor extraction, amplification, and detection for reliable results

NATtrol swabs can be customized to meet exact validation and verification needs. Options include target pathogen selection, multiplex configurations, swab type, kit format, and concentration levels.

From high-throughput hospital and reference laboratories to developers advancing next-generation assays, ZeptoMetrix NATtrol swab-based molecular controls deliver reproducibility, flexibility, and confidence in diagnostic workflows. By simplifying QC without compromising accuracy, these controls enable laboratories to focus on their primary mission: improving patient outcomes.

Learn more at www.zeptometrix.com

Supported by

Advertisement
Advertisement